A novel biomarker to improve the quality of life of immune mediated thrombotic thrombocytopenic purpura patients. Prof. Dr. Karen Vanhoorelbeke.
Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Belgium.
(2021 - 2023)
Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Belgium.
(2021 - 2023)